TOKYO, M0
Allocation by class
Portfolio Concentration
Top 3 weight
83.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.70M
Full voting authority
11.70M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Ovid Therapeutics, Inc.DFND | COM | 7.53M | SH | $9.79M 59.82% | 7.53M | 0.00 | 0.00 |
Equillium, Inc.DFND | COM | 1.82M | SH | $2.61M 15.94% | 1.82M | 0.00 | 0.00 |
Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)DFND | COM | 1.48M | SH | $1.24M 7.59% | 1.48M | 0.00 | 0.00 |
Shattuck Labs, Inc.DFND | COM | 515.62K | SH | $1.23M 7.53% | 515.62K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.DFND | COM | 54.89K | SH | $891.4K 5.45% | 54.89K | 0.00 | 0.00 |
American Well CorporationDFND | COM | 77.73K | SH | $478.1K 2.92% | 77.73K | 0.00 | 0.00 |
Rani Therapeutics Holdings, Inc.DFND | COM | 203.19K | SH | $101.6K 0.62% | 203.19K | 0.00 | 0.00 |
Standard Biotools, Inc.DFND | COM | 16.52K | SH | $21.5K 0.13% | 16.52K | 0.00 | 0.00 |